In humans, freshly isolated neuroblast susceptibility to lysis directly correlates with the surface expression of CD155 and either DNAM-1 or PVR masking with monoclonal antibodies, resulted in strong inhibition of tumor cell lysis [19]. This evidence concerns the gene CD226 and neoplasm.